Abstract
IntroductionSystemic sclerosis (SSc) is a connective tissue disorder characterised by the development of skin fibrosis. Our current understanding of the disease pathogenesis is incomplete and the study of SSc is hindered, at least partially, by a lack of animal models that fully replicate the complex state of human disease. Murine model of bleomycin-induced dermal fibrosis encapsulates important events that take place early in the disease course.MethodsTo characterise the optimum in vivo parameters required for the successful induction of dermal fibrosis we subjected three commonly used mouse strains to repeated subcutaneous bleomycin injections. We aimed to identify the effects of genetic background and gender on the severity of skin fibrosis. We used male and female Balb/C, C57BL/6, and DBA/2 strains and assessed their susceptibility to bleomycin-induced fibrosis by measuring dermal thickness, hydroxyproline/collagen content and number of resident myofibroblasts, all of which are important indicators of the severity of skin fibrosis. All data are expressed as mean values ± SEM. The Mann–Whitney U test was used for statistical analysis with GraphPad Prism 6.04 software.ResultsDermal fibrosis was most severe in Balb/C mice compared to C57BL/6 and DBA/2 suggesting that Balb/C mice are more susceptible to bleomycin-induced fibrosis. Analysis of the effect of gender on the severity of fibrosis showed that male Balb/C, C57BL/6, DBA/2 mice had a tendency to develop more pronounced fibrosis phenotype than female mice. Of potential importance, male Balb/C mice developed the most severe fibrosis phenotype compared to male C57BL/6 and male DBA/2 as indicated by significantly increased number of dermal myofibroblasts.ConclusionOur study highlights the importance of genetic background and gender in the induction of murine dermal fibrosis. Robust and reproducible animal models of fibrosis are important research tools used in pharmacological studies which may lead to better understanding of the pathogenesis of fibrotic diseases and assist in identification of new drugs.
Highlights
Systemic sclerosis (SSc) is a connective tissue disorder characterised by the development of skin fibrosis
Pro-fibrotic effects of subcutaneous bleomycin injections in the dermis of male Balb/C, C57BL/6 and DBA/2 mice To determine whether bleomycin had the same capacity to induce dermal fibrosis in three inbred mouse strains (Balb/C, C57BL/6 and DBA/2) that are frequently used for studies in dermal fibrosis research, we administered bleomycin at a concentration of 0.5 mg/ml, which was injected every other day for the period of 3 weeks
All values represent means ± standard error of the mean (SEM); n = 6 each group. n.s. not significant increased accumulation of collagen was observed in Balb/ C, C57BL/6 and DBA/2 skin when compared to NaCltreated controls (Fig. 1c; p = 0.0290 in Balb/C; p = 0.0001 in C57BL/6; p = 0.0103 in DBA/2)
Summary
Systemic sclerosis (SSc) is a connective tissue disorder characterised by the development of skin fibrosis. Murine model of bleomycin-induced dermal fibrosis encapsulates important events that take place early in the disease course. Systemic sclerosis (SSc) is an autoimmune disorder characterised by progressive connective tissue fibrosis and life-threatening complications with high mortality and morbidity [1]. The murine model of bleomycin-induced dermal fibrosis is widely used to study the changes that take place in the early phase of the disease [6]. Apart from its local effect, high-dose subcutaneous bleomycin injections are thought to induce lung fibrosis [7] and systemic autoimmune responses characterised by the presence of antinuclear autoantibodies, such as anti-Scl-70, anti-U1 RNP [9]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
